Edition:
United Kingdom

PAVmed Inc (PAVM.OQ)

PAVM.OQ on NASDAQ Stock Exchange Capital Market

1.62USD
19 Apr 2018
Change (% chg)

-- (--)
Prev Close
$1.62
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
13,911
52-wk High
$9.25
52-wk Low
$1.39

Chart for

About

PAVmed Inc. is a medical device company organized to conceive, develop and commercialize a diversified pipeline of products. The Company's products include PortIO, Caldus, CarpX, NextCath, DisappEAR and NextFlo. PortIO is an implantable vascular access device, which does not require accessing the central venous system and does... (more)

Overall

Beta: --
Market Cap(Mil.): $69.46
Shares Outstanding(Mil.): 13.33
Dividend: --
Yield (%): --

Financials

  PAVM.OQ Industry Sector
P/E (TTM): -- 148.40 32.74
EPS (TTM): -0.67 -- --
ROI: -- 9.37 14.38
ROE: -- 14.69 16.07

BRIEF-PAVmed Announces Firm Commitment Public Offering Of Common Stock

* PAVMED ANNOUNCES FIRM COMMITMENT PUBLIC OFFERING OF COMMON STOCK Source text for Eikon: Further company coverage:

18 Jan 2018

BRIEF-Pavmed Initiates Reduction In Exercise Price Of Series W Warrants

* PAVMED INITIATES REDUCTION IN EXERCISE PRICE OF SERIES W WARRANTS Source text for Eikon: Further company coverage:

11 Jan 2018

BRIEF-Pavmed Files 510(K) Submission With Fda For Carpx Device To Treat Carpal Tunnel Syndrome

* PAVMED FILES 510(K) SUBMISSION WITH FDA FOR CARPX™ DEVICE TO TREAT CARPAL TUNNEL SYNDROME

28 Nov 2017

BRIEF-Pavmed reports Q3 adjusted non-GAAP loss per share $0.13

* Q3 adjusted non-GAAP loss per share $0.13 Source text for Eikon: Further company coverage:

15 Nov 2017

BRIEF-Pavmed offers up to 2.7 mln shares

* Pavmed files for offering of up to 2.7 million shares of co that may be offered for resale by selling stockholders - SEC filing Source text: http://bit.ly/2iDN6XW Further company coverage:

08 Nov 2017

Earnings vs. Estimates